Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days
Two deals could bring NPE risk but others stem from bankruptcies, buying and selling of business units and company product collaborations
The volume of cases appears to be picking up pace in the Netherlands with key rulings offering guidance on confidentiality clubs and patenting of misappropriated trade secrets
A deep dive into the Supreme People’s Court’s multi-factor analysis in IWNCOMM v Apple illustrates that the decision of whether to grant injunctive relief involves a nuanced grasp of the different factors at issue and how they interact.
04 July 2024
Rouse highlights some of the most important pharma patent decisions issued by Southeast Asian courts in the past four years
04 July 2024
The new deal covers the Delaware-based patent licensing company’s wireless, Wi-Fi and HEVC portfolios
03 July 2024
When it’s risky that a PTAB proceeding might catch up to wrangling over damages in district court, collaboration between litigators and PTAB counsel is key
03 July 2024
In an increasingly digital world, some businesses are seeking the assistance of online marketplaces for cheaper, quasi-judicial patent enforcement
03 July 2024
Antitrust challenges against pharma patent strategies continue to escalate
02 July 2024
New lithium-ion battery licensing programme first step in company’s plans to extract volume from its 5,000-strong patent portfolio, IP Head Kazuki Kawakami tells IAM
02 July 2024
After the US Supreme Court overturned the Chevron doctrine on 28 June there are differing opinions on how USPTO rule-making packages will be impacted
01 July 2024
Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days
30 June 2024
Saturday Opinion: China is becoming increasingly self-sufficient, but complex technologies make innovation hard to achieve alone
29 June 2024
Unlock unlimited access to all IAM content
